Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HPGDS | O60760 | 1/20 | 0.53 |
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10891861 | 0.89 | KDM4E (0.51) | CYP3A4KMT2AHPGDSHMGCRLCK | |
| SCHEMBL20508037 | 0.87 | HPGDS (0.49) | CYP3A4KMT2AHPGDSHMGCRLCK | |
| SCHEMBL20507907 | 0.85 | HPGDS (0.47) | CYP3A4KMT2AHPGDSMEN1ALDH1A1 | |
| SCHEMBL14525270 | 0.85 | HPGDS (0.47) | CYP3A4KMT2AHPGDSHMGCRPAX8 | |
| SCHEMBL15680284 | 0.85 | LCK (0.65) | CYP3A4KMT2AHPGDSHMGCRLCK | |
| SCHEMBL7460397 | 0.83 | CYP3A4 (0.59) | CYP3A4KMT2AHMGCRLCKFYN | |
| SCHEMBL23173662 | 0.83 | HPGDS (0.49) | CYP3A4HPGDSHTTGSK3BALDH1A1 | |
| SCHEMBL6928976 | 0.83 | HPGDS (0.49) | CYP3A4KMT2AHPGDSHMGCRLCK | |
| SCHEMBL4764754 | 0.82 | HMGCR (0.72) | CYP3A4KMT2AHMGCRLCKFYN | |
| SCHEMBL679852 | 0.82 | CYP3A4 (0.62) | CYP3A4KMT2AHMGCRLCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5686424-A | FOR TREATING INFLAMMATION | MILES INC. (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | disclosed |